Anthony Bajoras is the Founder and Managing Director of CANCER FUND, established in January 2018, which focuses on investing in early-stage companies advancing cancer innovations. Anthony serves as an investor in multiple companies, including Veana Therapeutics, Inc., Avesta76 Therapeutics, and AOA Dx, all aimed at developing novel cancer treatments. Additionally, Anthony is involved with NearWave, which is improving breast cancer diagnosis and treatment, and Reglagene, working on drug treatments for brain cancers. Anthony holds limited partner positions in the Sonoran Founders Fund and Arizona Founders Fund and has served as Principal at CXO Advisors & Management since December 1999. Education includes a Bachelor of Science in Business Management & Entrepreneurship from DePaul University, complemented by graduate studies at Northwestern University and the Illinois Institute of Technology.
Links